Fatty acid binding protein 3 is associated with peripheral arterial disease
Muzammil H. Syed(St. Michael's Hospital), Mohammad Qadura(University of Toronto), Hamzah Khan(St. Michael's Hospital), Rawand Abdin(McMaster University), John W. Eikelboom(Population Health Research Institute), Abdelrahman Zamzam(St. Michael's Hospital), Ori D. Rotstein(St. Michael's Hospital), Thomas L. Forbes(University of Toronto), Krishna K. Singh(Western University)
Cited by 40
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
|New England Journal of Medicine|2017|2.4k
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
|New England Journal of Medicine|2013|1.5k